Thomas Arrhenius
24Patents
7h-index
31Co-inventors
65Inventor score
Filing activity: Mar 8, 1995 → May 3, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5770573A | CS-1 peptidomimetics, compositions and methods of using the same | Human Necessities | 95 | Expired |
| US5679640A | Immunosuppressant peptides | Chemistry; Metallurgy | 62 | Expired |
| US5821231A | CS-1 peptidomimetics, compositions and methods of using same | Human Necessities | 26 | Expired |
| US5936065A | CS-1 peptidomimetics, compositions and methods of using the same | Human Necessities | 18 | Expired |
| US7449482B2 | Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors | Human Necessities | 16 | Expired |
| US5688913A | CS-1 peptidomimetics, compositions and methods of using the same | Human Necessities | 13 | Expired |
| US5869448A | Cyclic CS-1 peptidomimetics, compositions and methods of using same | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5811391A | Cyclic CS-1 peptidomimetics, compositions and methods of using same | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7026491B2 | Coumarin derivatives useful as TNFα inhibitors | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7385063B2 | Method for preparing imidazole derivatives | Chemistry; Metallurgy | 3 | Expired |
| US6117840A | CS-1 peptidomimetics, compositions and methods of using the same | Human Necessities | 3 | Expired |
| US7524969B2 | Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators | Chemistry; Metallurgy | 3 | Expired |
| US5807979A | Synthetic, three-dimensionally stabilized polypeptide mimics of HIV | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7279477B2 | Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators | Chemistry; Metallurgy | 0 | Expired |
| US7709664B2 | Coumarin derivatives useful as TNFα inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US7723366B2 | Azole compounds as malonyl-CoA decarboxylase inhibitors for treating metabolic diseases | Human Necessities | 0 | Expired |
| US8119819B2 | Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators | Chemistry; Metallurgy | 0 | Active |
| US6103870A | CS-1 peptidomimetic, compositions and methods of using the same | Human Necessities | 0 | Expired |
| US7786145B2 | Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7994318B2 | Coumarin derivatives useful as TNFα inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8110686B2 | Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators | Chemistry; Metallurgy | 0 | Active |
| US7872142B2 | Coumarin derivatives useful as TNFα inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US7709510B2 | Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators | Chemistry; Metallurgy | 0 | Expired |
| US8080665B2 | Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.